SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-24-010792 to Albertsons Companies, Inc. (ACI) (CIK 0001646972) (ACI)

Albertsons Companies, Inc. (ACI) (CIK 0001646972)
Date: Sept. 23, 2024 · CIK: 0001646972 · Accession: 0000000000-24-010792

AI Filing Summary & Sentiment

File numbers found in text: 001-39350

Date
September 23, 2024
Author
Not clearly detected
Form
UPLOAD
Company
Albertsons Companies, Inc. (ACI) (CIK 0001646972)

Letter

September 23, 2024 Sharon McCollam President and Chief Financial Officer Albertsons Companies, Inc. 250 Parkcenter Blvd. Boise, Idaho 83706 Re:Albertsons Companies, Inc. Form 10-K for Fiscal Year Ended February 24, 2024 Filed April 22, 2024 File No. 001-39350 Dear Sharon McCollam: We have limited our review of your filing to the financial statements and related disclosures and have the following comment(s). Please respond to this letter within ten business days by providing the requested information or advise us as soon as possible when you will respond. If you do not believe a comment applies to your facts and circumstances, please tell us why in your response. After reviewing your response to this letter, we may have additional comments. Form 10-K for Fiscal Year Ended February 24, 2024 Item 7 - Management's Discussion and Analysis of Financial Condition and Results of Operations Reconciliation of Non-GAAP Measures, page 43 1.We note your Adjusted net income measure adjusts for business transformation expenses. In the related footnote, you describe these costs as operational priorities and associated business transformation. Please tell us the nature of your business transformation costs and your consideration of Question 100.01 of the Non-GAAP Financial Measures Compliance and Disclosure Interpretations. In particular, tell us how the excluded costs do not represent normal, recurring, cash operating expenses necessary to operate your business. In your calculation of "Adjusted net income per Class A common share - diluted" you adjust for the conversion of convertible preferred stock that would have been otherwise antidilutive, most notably for FY's 2022 and 2021. Your adjusted measure appears to have the effect of changing the antidilutive provisions of ASC 260-10-45. Please tell us how you concluded the noted adjustment does not represent an individually tailored accounting 2.

September 23, 2024 Page 2 principle. Refer to Question 100.04 of the Non-GAAP Financial Measures Compliance and Disclosure Interpretations. 3.Please revise to reconcile Adjusted EBITDA to the most comparable GAAP measure. Please refer to Item 10(e)(1)(i)(B) of Regulation S-K for further guidance.

In closing, we remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Aamira Chaudhry at 202-551-3389 or Abe Friedman at 202-551-8298 with any questions. Sincerely, Division of Corporation Finance Office of Trade & Services

Show Raw Text
September 23, 2024
Sharon McCollam
President and Chief Financial Officer
Albertsons Companies, Inc.
250 Parkcenter Blvd.
Boise, Idaho 83706
Re:Albertsons Companies, Inc.
Form 10-K for Fiscal Year Ended February 24, 2024
Filed April 22, 2024
File No. 001-39350
Dear Sharon McCollam:
            We have limited our review of your filing to the financial statements and related
disclosures and have the following comment(s).
            Please respond to this letter within ten business days by providing the requested
information or advise us as soon as possible when you will respond. If you do not believe a
comment applies to your facts and circumstances, please tell us why in your response.
            After reviewing your response to this letter, we may have additional comments.
Form 10-K for Fiscal Year Ended February 24, 2024
Item 7 - Management's Discussion and Analysis of Financial Condition and Results of Operations
Reconciliation of Non-GAAP Measures, page 43
1.We note your Adjusted net income measure adjusts for business transformation expenses.
In the related footnote, you describe these costs as operational priorities and associated
business transformation. Please tell us the nature of your business transformation costs
and your consideration of Question 100.01 of the Non-GAAP Financial Measures
Compliance and Disclosure Interpretations. In particular, tell us how the excluded costs
do not represent normal, recurring, cash operating expenses necessary to operate your
business.
In your calculation of "Adjusted net income per Class A common share - diluted" you
adjust for the conversion of convertible preferred stock that would have been otherwise
antidilutive, most notably for FY's 2022 and 2021. Your adjusted measure appears to have
the effect of changing the antidilutive provisions of ASC 260-10-45.  Please tell us how
you concluded the noted adjustment does not represent an individually tailored accounting 2.

September 23, 2024
Page 2
principle. Refer to Question 100.04 of the Non-GAAP Financial Measures Compliance
and Disclosure Interpretations.
3.Please revise to reconcile Adjusted EBITDA to the most comparable GAAP measure.
Please refer to Item 10(e)(1)(i)(B) of Regulation S-K for further guidance.

            In closing, we remind you that the company and its management are responsible for the
accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or
absence of action by the staff.
            Please contact Aamira Chaudhry at 202-551-3389 or Abe Friedman at 202-551-8298 with
any questions.
Sincerely,
Division of Corporation Finance
Office of Trade & Services